Novartis India Limited
NSE:NOVARTIND.NS
674 (INR) • At close October 25, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,562.7 | 3,350.7 | 3,691.1 | 3,875.7 | 3,656.1 | 4,113.5 | 4,503.4 | 5,171.9 | 6,095.7 | 6,897.7 | 8,733.8 | 8,622.3 | 9,033.6 | 8,442.9 | 7,512.1 | 6,241.03 | 5,994.802 | 5,534.476 | 5,414.904 | 5,253.439 | 4,711.813 |
| Cost of Revenue
| 2,028.2 | 2,023.8 | 2,046.2 | 1,814.8 | 1,496.3 | 1,853.6 | 2,021.1 | 2,497.6 | 3,114.4 | 2,914.8 | 3,576.1 | 3,930.7 | 3,716.5 | 3,114.8 | 2,754.5 | 2,512.705 | 2,524.155 | 2,455.746 | 4,309.088 | 4,168.618 | 3,855.748 |
| Gross Profit
| 1,534.5 | 1,326.9 | 1,644.9 | 2,060.9 | 2,159.8 | 2,259.9 | 2,482.3 | 2,674.3 | 2,981.3 | 3,982.9 | 5,157.7 | 4,691.6 | 5,317.1 | 5,328.1 | 4,757.6 | 3,728.325 | 3,470.647 | 3,078.73 | 1,105.816 | 1,084.821 | 856.065 |
| Gross Profit Ratio
| 0.431 | 0.396 | 0.446 | 0.532 | 0.591 | 0.549 | 0.551 | 0.517 | 0.489 | 0.577 | 0.591 | 0.544 | 0.589 | 0.631 | 0.633 | 0.597 | 0.579 | 0.556 | 0.204 | 0.206 | 0.182 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.2 | 0 | 0 | 0 | 0 | 0 | 8.427 | 16.155 | 6.949 |
| General & Administrative Expenses
| 0 | 67.8 | 64.2 | 79.5 | 64.1 | 86.5 | 119.6 | 105.5 | 112.4 | 102.2 | 85.6 | 0 | 103.3 | 397.9 | 323 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 158.7 | 279.8 | 356.6 | 397.7 | 539.9 | 602.9 | 724.8 | 758.3 | 707.4 | 786.3 | 0 | 906.8 | 931.5 | 821.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 185.5 | 226.5 | 344 | 436.1 | 461.8 | 626.4 | 722.5 | 830.3 | 870.7 | 809.6 | 871.9 | 1,465 | 3,846.9 | 1,329.4 | 1,144.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | 437.5 | 7.2 | 63.8 | 40.4 | 2.1 | 0.1 | 31.1 | 59.9 | 46.6 | 71.6 | 66.4 | 59.3 | 67.5 | 24.4 | 0 | 0 | 0 | -273.038 | -229.649 | -154.555 |
| Operating Expenses
| 185.5 | 659.6 | 1,040.4 | 1,888.5 | 2,011 | 2,248.6 | 2,351.3 | 2,740 | 2,755.3 | 3,633.8 | 5,013.2 | 4,674 | 4,425.7 | 3,877.6 | 2,932.2 | 1,939.053 | 1,827.988 | 1,627.019 | 281.465 | 245.804 | 161.504 |
| Operating Income
| 1,349 | 652.6 | 676.6 | 183.8 | 166.6 | 30.2 | 147.7 | -44.6 | 249.3 | 353.3 | 118.3 | 693.2 | 891.4 | 1,450.5 | 2,189.4 | 1,789.272 | 1,642.659 | 1,451.711 | 815.924 | 839.017 | 687.612 |
| Operating Income Ratio
| 0.379 | 0.195 | 0.183 | 0.047 | 0.046 | 0.007 | 0.033 | -0.009 | 0.041 | 0.051 | 0.014 | 0.08 | 0.099 | 0.172 | 0.291 | 0.287 | 0.274 | 0.262 | 0.151 | 0.16 | 0.146 |
| Total Other Income Expenses Net
| -44.8 | 575.8 | 477.2 | -275.9 | 233.8 | 273.5 | 725.1 | 1,619.8 | 675.3 | 764.6 | 800.3 | 5.4 | 993.6 | 796.4 | 363.7 | 8.733 | 35.38 | 48.287 | 481.966 | 611.528 | 352.781 |
| Income Before Tax
| 1,304.2 | 1,228.4 | 1,153.8 | -38.2 | 400.4 | 286.4 | 857.7 | 1,575.2 | 917.3 | 1,113.7 | 918.6 | 698.6 | 1,694.2 | 2,246.9 | 2,189.1 | 1,798.005 | 1,729.118 | 1,543.138 | 1,297.89 | 1,450.545 | 1,040.393 |
| Income Before Tax Ratio
| 0.366 | 0.367 | 0.313 | -0.01 | 0.11 | 0.07 | 0.19 | 0.305 | 0.15 | 0.161 | 0.105 | 0.081 | 0.188 | 0.266 | 0.291 | 0.288 | 0.288 | 0.279 | 0.24 | 0.276 | 0.221 |
| Income Tax Expense
| 295.2 | 376.5 | 120.2 | -1 | 191.4 | 185.6 | 340 | 791.6 | 345.1 | 388.8 | 125.3 | -158.8 | 496.9 | 726.7 | 722.4 | 638.113 | 692.021 | 570.792 | 412.409 | 371.635 | 389.241 |
| Net Income
| 1,009 | 851.9 | 1,033.6 | -37.2 | 209 | 100.8 | 517.7 | 783.6 | 572.2 | 1,982.9 | 791.1 | 985.3 | 1,197.3 | 1,520.2 | 1,466.7 | 1,159.892 | 1,037.097 | 972.346 | 885.481 | 1,078.91 | 651.152 |
| Net Income Ratio
| 0.283 | 0.254 | 0.28 | -0.01 | 0.057 | 0.025 | 0.115 | 0.152 | 0.094 | 0.287 | 0.091 | 0.114 | 0.133 | 0.18 | 0.195 | 0.186 | 0.173 | 0.176 | 0.164 | 0.205 | 0.138 |
| EPS
| 40.87 | 34.5 | 41.86 | -1.51 | 8.46 | 4.08 | 20.97 | 28.43 | 19.1 | 62.04 | 0.25 | 30.83 | 37.46 | 47.56 | 45.89 | 36.29 | 32.45 | 30.42 | 27.71 | 33.76 | 20.37 |
| EPS Diluted
| 40.87 | 34.5 | 41.86 | -1.51 | 8.46 | 4.08 | 20.97 | 28.43 | 19.1 | 62.04 | 0.25 | 30.83 | 37.46 | 47.56 | 45.89 | 36.29 | 32.45 | 30.42 | 27.71 | 33.76 | 20.37 |
| EBITDA
| 968.2 | 1,269.3 | 1,231.9 | 106.6 | 598.8 | 481.7 | 905.4 | 1,600.5 | 953.2 | 1,165.3 | 158.4 | 951.4 | 976.6 | 1,477.2 | 2,215.7 | 1,811.785 | 1,669.543 | 1,480.214 | 1,330.853 | 1,482.89 | 1,100.1 |
| EBITDA Ratio
| 0.272 | 0.379 | 0.334 | 0.028 | 0.164 | 0.117 | 0.201 | 0.309 | 0.156 | 0.169 | 0.018 | 0.11 | 0.108 | 0.175 | 0.295 | 0.29 | 0.278 | 0.267 | 0.246 | 0.282 | 0.233 |